Redsense Medical AB Statistics
Total Valuation
RDSNF has a market cap or net worth of 10.16 million. The enterprise value is 8.51 million.
| Market Cap | 10.16M |
| Enterprise Value | 8.51M |
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025.
| Earnings Date | Aug 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 16.44M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +25.74% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| PB Ratio | 2.72 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -502.64 |
| EV / Sales | 2.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -19.81 |
Financial Position
The company has a current ratio of 11.64
| Current Ratio | 11.64 |
| Quick Ratio | 7.97 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.03 |
Financial Efficiency
Return on equity (ROE) is -0.59% and return on invested capital (ROIC) is -0.63%.
| Return on Equity (ROE) | -0.59% |
| Return on Assets (ROA) | -0.58% |
| Return on Invested Capital (ROIC) | -0.63% |
| Return on Capital Employed (ROCE) | -0.77% |
| Revenue Per Employee | 635,955 |
| Profits Per Employee | -3,387 |
| Employee Count | 5 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 2.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.32 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 229 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RDSNF had revenue of 3.18 million and -16,936 in losses. Loss per share was -0.00.
| Revenue | 3.18M |
| Gross Profit | 1.92M |
| Operating Income | -28,791 |
| Pretax Income | -16,936 |
| Net Income | -16,936 |
| EBITDA | -22,216 |
| EBIT | -28,791 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 1.60 million in cash and n/a in debt, giving a net cash position of 1.60 million.
| Cash & Cash Equivalents | 1.60M |
| Total Debt | n/a |
| Net Cash | 1.60M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.73M |
| Book Value Per Share | 0.23 |
| Working Capital | 2.35M |
Cash Flow
In the last 12 months, operating cash flow was -427,982 and capital expenditures -1,694, giving a free cash flow of -429,676.
| Operating Cash Flow | -427,982 |
| Capital Expenditures | -1,694 |
| Free Cash Flow | -429,676 |
| FCF Per Share | n/a |
Margins
Gross margin is 60.46%, with operating and profit margins of -0.91% and -0.53%.
| Gross Margin | 60.46% |
| Operating Margin | -0.91% |
| Pretax Margin | -0.53% |
| Profit Margin | -0.53% |
| EBITDA Margin | -0.70% |
| EBIT Margin | -0.91% |
| FCF Margin | n/a |
Dividends & Yields
RDSNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.74% |
| Shareholder Yield | -25.74% |
| Earnings Yield | -0.17% |
| FCF Yield | -4.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RDSNF has an Altman Z-Score of 32.74 and a Piotroski F-Score of 3.
| Altman Z-Score | 32.74 |
| Piotroski F-Score | 3 |